TEL AVIV, Israel, May 04, 2020 (GLOBE NEWSWIRE) -- VBL Therapeutics VBLT, a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced that it will host a conference call and live audio webcast on Thursday, May 14, 2020 at 8:30am Eastern Time to report first quarter ended March 31, 2020 financial results and to provide a corporate update.
Thursday May 14th @ 8:30amET | ||
From the US: | 877-407-9208 | |
International: | 201-493-6784 | |
Israel: | 1 809 406 247 | |
Conference ID: | 13703295 | |
Webcast: | https://edge.media-server.com/mmc/p/ubiyng5a | |
About VBL
Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for areas of unmet need in cancer and immune/inflammatory indications.
INVESTOR CONTACT:
Michael Rice
LifeSci Advisors, LLC
(646) 597-6979
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.